Physician

David J Myers, M.D.

According to 2025 Medicare claims, David Myers, M.D. (NPI: 1255425252) practices dermatology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is UTAH VALLEY DERMATOLOGY PC (NPI: 1922368927; TIN: 45-5330549) and primary practice location at 84043-2251.

Myers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 401 traditional Medicare patients, billed 5,348 HCPCS/CPT codes, and received $227,133 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 370 prescription claims across 208 beneficiaries totaling $24,627 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 85 records totaling $1,580. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $147,281 to $227,133. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $17,821 and ending at $24,627. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$114K$227K2015 Medicare payment: $147,281 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $129,895 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $194,507 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $200,172 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $186,146 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $172,214 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $163,209 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $212,497 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $208,989 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $227,133 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152582,425$147,281
20162802,188$129,895
20173522,881$194,507
20183723,714$200,172
20193805,090$186,146
20203806,076$172,214
20213373,555$163,209
20223855,956$212,497
20234027,330$208,989
20244015,348$227,133

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$27K$53K2015 Drug cost: $17,821 (USD; Tot_Drug_Cst)2016 Drug cost: $18,394 (USD; Tot_Drug_Cst)2017 Drug cost: $18,229 (USD; Tot_Drug_Cst)2018 Drug cost: $14,557 (USD; Tot_Drug_Cst)2019 Drug cost: $11,750 (USD; Tot_Drug_Cst)2020 Drug cost: $21,832 (USD; Tot_Drug_Cst)2021 Drug cost: $53,211 (USD; Tot_Drug_Cst)2022 Drug cost: $13,796 (USD; Tot_Drug_Cst)2023 Drug cost: $16,569 (USD; Tot_Drug_Cst)2024 Drug cost: $24,627 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015144313$17,821
2016174322$18,394
2017197400$18,229
2018204432$14,557
2019168354$11,750
2020169291$21,832
2021154270$53,211
2022187342$13,796
2023192310$16,569
2024208370$24,627

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths197257$71
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more287430$58
88305Pathology examination of tissue using a microscope, intermediate complexity248498$54
11102Biopsy of related skin growth, first growth206260$53
17000Destruction of precancer skin growth, 1 growth219298$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate872,225$3,021
FluconazoleFluconazole271,270$457
ImiquimodImiquimod16485$442
ValacyclovirValacyclovir Hcl17197$400
Minocycline HclMinocycline Hcl14607$395

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.85$1,580Dermavant Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David J. Myers, M.D.?

Tedicare shows public-source Medicare data for David J. Myers, M.D. (NPI 1255425252), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David J. Myers, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David J. Myers, M.D.?

David J. Myers, M.D. is linked to UTAH VALLEY DERMATOLOGY PC (billing NPI 1922368927) in the available physician profile data.

Does David J. Myers, M.D. have Open Payments data?

David J. Myers, M.D. has 85 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.